Abstract:The dynamic interactions between macrophages and T-lymphocytes in the tumor microenvironment exert both antagonistic and synergistic functions affecting tumor growth. Extensive experimental effort has been expended to investigate immunotherapeutic strategies targeting macrophage polarization as well as T-cell activation with the goal to promote tumor cell killing and cancer elimination. However, these interactions remain poorly understood, and cancer immunotherapeutic strategies are often disappointing. The complex system encompassing innate and adaptive immune cell activity in response to tumor growth could benefit from a systems perspective built upon mathematical modeling. This study develops a modeling system to help evaluate the effects of macrophage and T-lymphocyte interactions on tumor growth. The system enables simulating the combined cytotoxic and tumor-promoting interactions of these two immune cell populations in a vascularized organ microenvironment, such as in liver metastases. A hypothetical immunotherapeutic strategy is simulated to increase the number of tumor-suppressive (M1-phenotype) vs. tumor-promoting (M2-phenotype) macrophages to gauge their effects on CD8<sup>+</sup> T-cells and CD4<sup>+</sup> T-helper cells, which in turn affect the macrophage functions. The results highlight the dynamic interactions between macrophages and T-lymphocytes in the tumor microenvironment and show that with the chosen set of parameter values, the overall cytotoxic effect from macrophages and T-lymphocytes obtained by driving the M1:M2 ratio higher could saturate and fail to achieve tumor regression. Further expansion of this modeling platform to include additional tumor-immune cell interactions, coupled with parameters representing particular tumor characteristics, could enable systematic evaluation of immunotherapeutic strategies tailored to patient-tumor specific conditions, including metastatic disease.

Agent-based modeling of tumor-immune interactions reveals determinants of final tumor states

A mathematical model of tumor-immune interactions incorporated with danger model

Integrating mechanism-based T cell phenotypes into a model of tumor-immune cell interactions

Mathematical modeling of tumor-associated macrophage interactions with the cancer microenvironment

Agent-Based Modeling of Virtual Tumors Reveals the Critical Influence of Microenvironmental Complexity on Immunotherapy Efficacy

Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment

Data-driven mathematical modeling and quantitative analysis of cell dynamics in the tumor microenvironment

Multi-scale modeling of macrophage—T cell interactions within the tumor microenvironment

Quantitative Modeling to Understand Cell Signaling in the Tumor Microenvironment

Modelling the tumor immune microenvironment for precision immunotherapy

Immune cells interactions in the tumor microenvironment

Addressing current challenges in cancer immunotherapy with mathematical and computational modeling

Computational Modeling of the Crosstalk Between Macrophage Polarization and Tumor Cell Plasticity in the Tumor Microenvironment

Mathematical model of tumor immune microenvironment with application to the combined therapy targeting the PD-1/PD-L1 pathway and IL-10 cytokine antibody

Modeling of Tumor Growth with Input from Patient-Specific Metabolomic Data

Mathematical modeling of cancer immunotherapy for personalized clinical translation

Spatial computational modelling illuminates the role of the tumour microenvironment for treating glioblastoma with immunotherapies

Computational Modeling to Determine the Effect of Phenotypic Heterogeneity in Tumors on the Collective Tumor–Immune Interactions

Hybrid discrete‐continuum modeling of tumor‐immune interactions: Fractional time and space analysis with immunotherapy

Algorithmic asymptotic analysis: extending the arsenal of cancer immunology modeling